User profiles for W. W. Lockwood
William LockwoodSenior Scientist, British Columbia Cancer Agency - Associate Professor, University of British Verified email at bccrc.ca Cited by 6309 |
Lung cancer cell lines as tools for biomedical discovery and research
AF Gazdar, L Girard, WW Lockwood… - Journal of the …, 2010 - academic.oup.com
Lung cancer cell lines have made a substantial contribution to lung cancer translational
research and biomedical discovery. A systematic approach to initiating and characterizing cell …
research and biomedical discovery. A systematic approach to initiating and characterizing cell …
[HTML][HTML] Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
…, JY Kennett, KL Bennewith, WW Lockwood… - Molecular cancer, 2016 - Springer
Lung cancer is a leading cause of cancer-related deaths worldwide. Lung cancer risk factors,
including smoking and exposure to environmental carcinogens, have been linked to …
including smoking and exposure to environmental carcinogens, have been linked to …
[BOOK][B] Economic development of Japan
WW Lockwood - 2015 - books.google.com
The rise of Japan from agrarianism to a position as one of the leading industrial powers is
one of the most dramatic and meaningful phenomena in economic history. Professor …
one of the most dramatic and meaningful phenomena in economic history. Professor …
[HTML][HTML] Recent advances in array comparative genomic hybridization technologies and their applications in human genetics
Array comparative genomic hybridization (array CGH) is a method used to detect segmental
DNA copy number alterations. Recently, advances in this technology have enabled high-…
DNA copy number alterations. Recently, advances in this technology have enabled high-…
PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
…, H Shigematsu, M Nomura, WW Lockwood… - Cancer research, 2008 - AACR
We investigated the frequency and function of mutations and increased copy number of the
PIK3CA gene in lung cancers. PIK3CA mutations are one of the most common gene changes …
PIK3CA gene in lung cancers. PIK3CA mutations are one of the most common gene changes …
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
WW Lockwood, K Zejnullahu… - Proceedings of the …, 2012 - National Acad Sciences
Bromodomain and extra terminal domain (BET) proteins function as epigenetic signaling
factors that associate with acetylated histones and facilitate transcription of target genes. …
factors that associate with acetylated histones and facilitate transcription of target genes. …
[HTML][HTML] Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells
J Soh, N Okumura, WW Lockwood, H Yamamoto… - PloS one, 2009 - journals.plos.org
Background Activating mutations in one allele of an oncogene (heterozygous mutations)
are widely believed to be sufficient for tumorigenesis. However, mutant allele specific …
are widely believed to be sufficient for tumorigenesis. However, mutant allele specific …
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance
…, S von Karstedt, WW Lockwood… - Proceedings of the …, 2019 - National Acad Sciences
The RAS family of proto-oncogenes are among the most commonly mutated genes in human
cancers and predict poor clinical outcome. Several mechanisms underlying oncogenic …
cancers and predict poor clinical outcome. Several mechanisms underlying oncogenic …
[HTML][HTML] Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines
…, H Yamamoto, M Peyton, L Girard, WW Lockwood… - PloS one, 2009 - journals.plos.org
Background Deregulation of EGFR signaling is common in non-small cell lung cancers (NSCLC)
and this finding led to the development of tyrosine kinase inhibitors (TKIs) that are …
and this finding led to the development of tyrosine kinase inhibitors (TKIs) that are …
[HTML][HTML] TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer
DT Starczynowski, WW Lockwood… - The Journal of …, 2011 - Am Soc Clin Investig
… Lockwood and R. Chari were supported by a doctoral research award from the Natural
Sciences and Engineering Research Council of Canada, CIHR, and MSFHR. A. …
Sciences and Engineering Research Council of Canada, CIHR, and MSFHR. A. …